These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 36250365)

  • 21. Symptom Scores and pH-Impedance: Secondary Analysis of a Randomized Controlled Trial in Infants Treated for Gastroesophageal Reflux.
    Sultana Z; Hasenstab KA; Moore RK; Osborn EK; Yildiz VO; Wei L; Slaughter JL; Jadcherla SR
    Gastro Hep Adv; 2022; 1(5):869-881. PubMed ID: 36310566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does severe and chronic esophageal distension by air (observed in SGB and GB) affect the esophageal mucosa integrity (MNBI).
    Voulgaris T; Hoshino S; Sifrim D; Yazaki E
    Neurogastroenterol Motil; 2024 Mar; 36(3):e14731. PubMed ID: 38148498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing different diagnostic tests for gastroesophageal reflux disease: a systematic review and network meta-analysis.
    Zhang M; Pandolfino JE; Zhou X; Tan N; Li Y; Chen M; Xiao Y
    Therap Adv Gastroenterol; 2019; 12():1756284819890537. PubMed ID: 31803253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prediction model of abnormal acid reflux in gastroesophageal reflux disease.
    Sonoda M; Matsumura T; Dao HV; Shiko Y; Do PN; Nguyen BP; Okimoto K; Akizue N; Ohyama Y; Mamiya Y; Nakazawa H; Takahashi S; Horio R; Goto C; Kurosugi A; Kaneko T; Ohta Y; Saito K; Taida T; Kikuchi A; Fujie M; Kato J; Dao LV; Kato N
    J Gastroenterol Hepatol; 2024 May; ():. PubMed ID: 38747056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton pump inhibitor therapy may alter the sensory motor characteristics of pharyngoesophageal motility in infants with suspected GERD.
    Jadcherla SR; Helmick R; Hasenstab KA; Njeh M; Yildiz VO; Wei L; Slaughter JL; Di Lorenzo C
    Neurogastroenterol Motil; 2024 Mar; 36(3):e14730. PubMed ID: 38155406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pilot study of an endoluminal-suturing device as a treatment for patients with gastroesophageal reflux disease.
    Louis H; Van Ouytsel P; Leclercq L; Houinsou Hans M; Devière J; Rio-Tinto R; Huberty V
    Endosc Int Open; 2023 Nov; 11(11):E1092-E1098. PubMed ID: 38026783
    [No Abstract]   [Full Text] [Related]  

  • 27. Diagnostic Investigations of Gastroesophageal Reflux Disease: Who and When to Refer and for What Test?
    Kandulski A; Moleda L; Müller-Schilling M
    Visc Med; 2018 Apr; 34(2):97-100. PubMed ID: 29888237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left lateral decubitus sleeping position is associated with improved gastroesophageal reflux disease symptoms: A systematic review and meta-analysis.
    Simadibrata DM; Lesmana E; Amangku BR; Wardoyo MP; Simadibrata M
    World J Clin Cases; 2023 Oct; 11(30):7329-7336. PubMed ID: 37969463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A reduced esophageal epithelial integrity in a subgroup of healthy individuals increases with proton pump inhibitor therapy.
    Pauwels A; Broers C; Vanuytsel T; Pardon N; Cocca S; Roman S; Zerbib F; Tack J; Farré R
    United European Gastroenterol J; 2018 May; 6(4):511-518. PubMed ID: 29881606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on extraesophageal manifestations of gastroesophageal reflux.
    Fernandez AM; Chan WW
    Curr Opin Gastroenterol; 2024 Jul; 40(4):305-313. PubMed ID: 38662405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of proximal mean nocturnal basal impedance in gastroesophageal reflux disease-A preliminary experience.
    Prajapati SK; Senthamizhselvan K; Murugesan R; Mohan P
    Indian J Gastroenterol; 2024 Apr; ():. PubMed ID: 38619808
    [No Abstract]   [Full Text] [Related]  

  • 32. How to diagnose GERC more effectively: reflections on post-reflux swallow-induced peristaltic wave index and mean nocturnal baseline impedance.
    Sha B; Li W; Bai H; Zhang T; Wang S; Shi W; Wen S; Yu L; Xu X
    BMC Pulm Med; 2024 Jun; 24(1):269. PubMed ID: 38840152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical use of mean nocturnal baseline impedance and post-reflux swallow-induced peristaltic wave index for the diagnosis of gastro-esophageal reflux disease.
    Visaggi P; Mariani L; Svizzero FB; Tarducci L; Sostilio A; Frazzoni M; Tolone S; Penagini R; Frazzoni L; Ceccarelli L; Savarino V; Bellini M; Gyawali PC; Savarino EV; de Bortoli N
    Esophagus; 2022 Oct; 19(4):525-534. PubMed ID: 35768671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Mean Nocturnal Baseline Impedance and Post-Reflux Swallow-Induced Peristaltic Wave Index in the Diagnosis and Treatment of Gastroesophageal Reflux Disease.
    Liao S; Hao J; Zhou J; Cheng Y; Gao X; Wu Y; Cheng Y
    Dig Dis; 2023; 41(1):1-9. PubMed ID: 36349754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mean Nocturnal Baseline Impedance and Post-reflux Swallow-induced Peristaltic Wave Index Could Identify Gastroesophageal Reflux Disease but pH-Impedance Metrics Alone Might Not Correlate With Proton Pump Inhibitor Response in Chinese Patients With Typical Reflux Symptoms.
    Wang D; Duan C; Zhang X; Xu J; Hou X; Xiang X
    J Neurogastroenterol Motil; 2022 Oct; 28(4):580-588. PubMed ID: 36250365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance can link PPI-responsive heartburn to reflux better than acid exposure time.
    Frazzoni L; Frazzoni M; de Bortoli N; Tolone S; Furnari M; Martinucci I; Bertani H; Marchi S; Conigliaro R; Fuccio L; Savarino V; Savarino E
    Neurogastroenterol Motil; 2017 Nov; 29(11):. PubMed ID: 28543861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel impedance-pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro-oesophageal reflux disease according to Lyon Consensus.
    Ribolsi M; Frazzoni M; Marabotto E; De Carlo G; Ziola S; Maniero D; Balestrieri P; Cicala M; Savarino E
    Aliment Pharmacol Ther; 2021 Aug; 54(4):412-418. PubMed ID: 34181753
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.